News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,332 Results
Type
Article (14136)
Company Profile (282)
Press Release (250914)
Section
Business (79471)
Career Advice (153)
Deals (13221)
Drug Delivery (35)
Drug Development (50414)
Employer Resources (31)
FDA (5708)
Job Trends (5127)
News (144324)
Policy (10027)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (907)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21616)
ALS (54)
Alzheimer's disease (807)
Antibody-drug conjugate (ADC) (79)
Approvals (5714)
Artificial intelligence (100)
Autoimmune disease (7)
Automation (5)
Bankruptcy (102)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (35)
Biotechnology (232)
Bladder cancer (40)
Brain cancer (19)
Breast cancer (132)
Cancer (1174)
Cardiovascular disease (92)
Career advice (132)
Career pathing (2)
CAR-T (101)
Cell therapy (291)
Cervical cancer (5)
Clinical research (40671)
Collaboration (462)
Compensation (196)
Complete response letters (13)
COVID-19 (1029)
CRISPR (33)
C-suite (129)
Cystic fibrosis (75)
Data (1212)
Denatured (11)
Depression (27)
Diabetes (112)
Diagnostics (1283)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (74)
Drug pricing (27)
Drug shortages (3)
Duchenne muscular dystrophy (64)
Earnings (29389)
Editorial (16)
Employer branding (4)
Employer resources (29)
Events (47887)
Executive appointments (377)
FDA (6262)
Featured Employer (34)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (432)
Gene editing (80)
Generative AI (9)
Gene therapy (210)
GLP-1 (341)
Government (1074)
Grass and pollen (2)
Guidances (17)
Healthcare (6585)
Huntington's disease (21)
IgA nephropathy (18)
Immunology and inflammation (71)
Indications (16)
Infectious disease (1083)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (51)
Interviews (17)
IPO (7255)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (198)
Leadership (2)
Legal (1385)
Liver cancer (29)
Lung cancer (168)
Lymphoma (77)
Machine learning (1)
Management (7)
Manufacturing (107)
MASH (46)
Medical device (2584)
Medtech (2585)
Mergers & acquisitions (6219)
Metabolic disorders (334)
Multiple sclerosis (46)
NASH (13)
Neurodegenerative disease (53)
Neuropsychiatric disorders (22)
Neuroscience (1144)
NextGen: Class of 2025 (2014)
Non-profit (852)
Northern California (1415)
Now hiring (21)
Obesity (173)
Opinion (98)
Ovarian cancer (50)
Pain (38)
Pancreatic cancer (48)
Parkinson's disease (94)
Partnered (6)
Patents (98)
Patient recruitment (56)
Peanut (35)
People (25414)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14356)
Phase II (18922)
Phase III (11956)
Pipeline (575)
Podcasts (42)
Policy (33)
Postmarket research (852)
Preclinical (6014)
Press Release (30)
Prostate cancer (49)
Psychedelics (35)
Radiopharmaceuticals (210)
Rare diseases (262)
Real estate (1414)
Recruiting (12)
Regulatory (8496)
Reports (14)
Research institute (935)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (1)
RSV (10)
Schizophrenia (52)
Series A (85)
Series B (51)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1256)
Special edition (10)
Sponsored (11)
Startups (1969)
State (1)
Stomach cancer (4)
Supply chain (17)
The Weekly (31)
United States (11196)
Vaccines (195)
Venture capitalists (27)
Webinars (7)
Weight loss (97)
Women's health (14)
Worklife (2)
Date
Last 7 days (395)
Last 30 days (1605)
Last 365 days (20179)
2025 (3510)
2024 (20552)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (37)
Alaska (2)
Arizona (50)
Arkansas (5)
Asia (17142)
Australia (2902)
California (3231)
Canada (997)
China (290)
Colorado (125)
Connecticut (136)
Delaware (78)
Europe (36868)
Florida (376)
Georgia (95)
Idaho (16)
Illinois (200)
India (6)
Indiana (79)
Iowa (1)
Japan (63)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (424)
Massachusetts (2564)
Michigan (68)
Minnesota (124)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (14)
New Hampshire (13)
New Jersey (811)
New Mexico (11)
New York (890)
North Carolina (497)
North Dakota (4)
Northern California (1415)
Ohio (102)
Oklahoma (8)
Oregon (21)
Pennsylvania (608)
Puerto Rico (1)
Rhode Island (13)
South America (207)
South Carolina (3)
Southern California (1256)
Tennessee (24)
Texas (365)
Utah (45)
Virginia (65)
Washington D.C. (27)
Washington State (302)
Wisconsin (13)
265,332 Results for "contineum therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Contineum Therapeutics to Present at the 2025 Leerink Partners Global Healthcare Conference
March 3, 2025
·
1 min read
Press Releases
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791
March 4, 2025
·
5 min read
Press Releases
Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
March 6, 2025
·
11 min read
Press Releases
Contineum Therapeutics to Attend Upcoming Investor Conferences
November 14, 2024
·
1 min read
Business
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
Contineum Therapeutics, Inc. (Nasdaq: CTNM) today announced the appointment of Sarah Boyce, President and Chief Executive Officer of Avidity Biosciences, Inc. (Nasdaq: RNA), as an independent member of its Board of Directors.
June 24, 2024
·
5 min read
Business
Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
Contineum Therapeutics, Inc. announced the appointment of Troy Ignelzi as an independent member of its Board of Directors and as Chair of the Audit Committee.
May 20, 2024
·
5 min read
Press Releases
Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference
November 25, 2024
·
1 min read
Biotech Beach
Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
Contineum Therapeutics, Inc. (Nasdaq: CTNM) today announced that Company management will participate in the 45th Annual Goldman Sachs Healthcare Conference, taking place June 10-13, 2024 in Miami.
June 4, 2024
·
1 min read
Press Releases
Contineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
January 9, 2025
·
5 min read
Business
Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary
Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of neuroscience, inflammation and immunology indications, announced the appointment of John Healy as General Counsel & Corporate Secretary.
June 3, 2024
·
4 min read
1 of 26,534
Next
